Immunomodulatory properties of selectively processed prawn protein fractions assessed using human peripheral blood mononuclear cells by Faisal, Md et al.
Original article
Immunomodulatory properties of selectively processed prawn
protein fractions assessed using human peripheral blood
mononuclear cells
Md Faisal, Narges Dargahi, Todor Vasiljevic & Osaana N. Donkor*
Advanced Food Systems Research Unit, Institute of Sustainable Industries & Liveable Cities and College of Health and Biomedicine,
Victoria University, Werribee Campus, PO Box 14428, Melbourne, Victoria 8001, Australia
(Received 10 July 2019; Accepted in revised form 2 August 2019)
Summary Prawn muscles were treated with acetic acid and high-pressure processing (600 MPa) separately to analyse
their antigenicity and immunogenicity. The protein fractions were separated and isolated using preparative
HPLC, and their antigenicity was analysed using Immunoglobulin G (IgG) ELISA kit. Out of thirty-nine
protein fractions, only four (A10, A11, B10 and C9) were detected with antigenic potentials. The immuno-
genicity of these protein fractions was analysed using human PBMCs, and supernatants were collected at
multiple times from 0 to 144 h. The treated fractions (B10 and C9) analysed using Immunoglobulin E (IgE)
ELISA kit showed signiﬁcantly (P < 0.05) lower pro- and anti-inﬂammatory cytokine production compared
with control (A10). The allergenic fractions were characterised using an LC/MS/MS, which identiﬁed nine
proteins. Among these, six proteins (tropomyosin, arginine kinase, haemocyanin, enolase, vitellogenin and
14-3-3 zeta) have been established as allergenic in prawn muscle and ovaries. Other three proteins (beta-1,3-
glucan-binding protein, translationally controlled tumour protein and farnesoic acid O-methyltransferase
short isoform protein) identiﬁed in this study need further investigation for their immunogenic properties.
Keywords Antigenicity, immunogenicity, interleukin cytokine, LC/MS/MS, PBMCs, prawn allergy.
Introduction
Prawn allergy is one of the major causes of food-borne
allergies, responsible for most severe food allergy-re-
lated emergency department visits (Sicherer et al., 2004;
Liu et al., 2008). The upward trend of prawn-induced
allergic incidents has now become an alarming issue in
global food safety (Sicherer & Sampson, 2006). The
major allergen in prawn protein, known as tropomyo-
sin, is responsible for over 80% prawn allergy-related
incidents. It is a 37 kDa heat-stable muscle protein hav-
ing an a-helical structure associated with actin ﬁlaments
(Troiano, 2016; Faisal et al., 2019c). Beside this protein,
arginine kinase, myosin light chain, actin, troponin,
haemocyanin and sarcoplasmic calcium-binding protein
are also known as minor allergen in prawns (Rahman
et al., 2013; Kamath et al., 2014; Khanaruksombat
et al., 2014). Prawn allergy is an IgE-mediated type 1
allergy showing symptoms of severe mucocutaneous,
respiratory, gastrointestinal, anaphylactic and cardio-
vascular (95.7%, 23.9%, 16.3%, 11.9% and 3.3%,
respectively) disorders (Sicherer, 2011; Pedrosa et al.,
2015). In previous studies, Ayuso et al. (2002) and
Zheng et al. (2011) reported eight IgE-binding epitopes,
whereas Wang et al. (2012) reported 17 IgE-binding epi-
topes on tropomyosin. As per literature, the hypersensi-
tivity reactions due to binding of protein epitopes with
IgE antibodies are termed as allergenicity, whereas
binding with IgG antibodies is known as antigenicity
(Verhoeckx et al., 2015; Bogahawaththa et al., 2017).
Moreover, when allergic components stimulate the
immune system of the human body involving generation
of speciﬁc IgE antibodies, the resulting stimulation is
known as immunogenicity (Actor, 2014).
Wang et al. (2012) and Ravkov et al. (2013) reported
the ability of allergenic protein to activate and proliferate
T-helper (Th) cells in human peripheral blood mononu-
clear cells (PBMCs). PBMCs have been extensively stud-
ied in immunological research due to the presence of
highly sophisticated immune cells lending their applica-
tion in in vitro studies. PBMCs have often been co-cul-
tured with various immune stimulants in vitro, to
determine their eﬃcacy considering various parameters
of immune responses, such as cytokine production*Correspondent: Fax: +61 3 9919 8284;
e-mail: Osaana.Donkor@vu.edu.au
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(Ramachandran et al., 2012). The Th cells, including Th1
and Th2 subsets, play important role in interfering with
the immune defence through the antibody or cell-medi-
ated immune responses. In addition, the balance between
Th1 and Th2 maintained by secretion of certain types of
interleukin (IL) (such as IL-2, IL-4, IL-10 and IFN-c) is
believed to maintain the homeostasis of immune response
(Donkor et al., 2012; Wang et al., 2012). In addition,
Th17 cells release pro-inﬂammatory IL-17 cytokines and
may diﬀerentiate into Th1 or Treg (T regulatory) cells to
regulate the balance between Th1 and Th2 cells (Korn
et al., 2009; Galvez, 2014).
To minimise human health risk due to allergic reac-
tions, several researchers endeavoured to prepare
hypoallergenic prawn products through structural
modiﬁcation of tropomyosin using various processing
technologies (Kamath et al., 2014; Lasekan & Nayak,
2016; Lv et al., 2017; Yuan et al., 2017; Faisal et al.,
2019c). In previous studies, Faisal et al. (2019a,c)
reported a signiﬁcant reduction of antigenicity (IgG
binding) of tropomyosin in high-pressure-processed
(600 MPa) and acetic acid-treated prawn samples
using immunoblotting and ELISA kits. Considering
that the in vitro immunoassays often use crude protein
extracts to measure the changes of the speciﬁc IgE sen-
sitivity based on patient serum, the aﬀectability and
explicitness of the test are not constantly acceptable in
distinguishing the actual allergenicity (Morita et al.,
2013; Leung et al., 2014; Abramovitch et al., 2017).
Moreover, the crude extract contains a great deal of
diﬀerent types of protein matrices, which often creates
diﬃculties to point out the role of speciﬁc proteins for
IgE reactivity (Faisal et al., 2019c). To resolve this
problem, the use of puriﬁed allergenic proteins
becomes indispensable to diagnose the speciﬁc IgE sen-
sitivity more accurately (Morita et al., 2013; Leung
et al., 2014). Beside this, the study on cellular immune
reactivity of isolated protein fractions is limited to
reveal the role of Th cells completely. Therefore, the
present study aimed to examine the immunogenicity
(Th cell-mediated immune response in vitro) of isolate
protein fractions in native and processed (acetic acid
and high pressure treated in combination with high
temperature) banana prawn samples up to certain time
using human PBMC, as well as identify and charac-
terise the protein fractions using liquid chromatogra-
phy with tandem mass spectrometry (LC/MS/MS).
Materials and methods
Treatment and extraction of proteins from prawn
Fresh banana prawns (Fenneropenaeus merguiensis)
were purchased from a local supermarket in Melbourne,
Australia. Prawn samples were washed with distilled
water, deshelled and deveined prior to all treatments.
High-pressure processing (HPP) of prawn muscle was
performed using a Stansted ISO-LAB FPG11501 High
Pressure 3.6 L unit (Stansted Fluid Power Ltd., Stansted,
Essex, UK). The pressure vessel has a permitted initial
temperature range from 20 to 110 °C for pressures up to
800 MPa. The maximum temperature within the vessel
during pressure holding was 130 °C. A deionised water/
propylene-glycol mixture (40% glycol) was used as the
pressure-transmitting medium (Knoerzer et al., 2010). The
processing of prawn sample with high pressure (600 MPa)
at 120 °C for 10 min was executed as described by Faisal
et al. (2019a). In brief during high-pressure treatment, the
vessel was conditioned to an initial temperature (90 °C),
which then attained the target temperature after compres-
sion heating. Conditioning times for samples were short
(<2 min) but varied slightly depending on the applied tem-
perature. The compression and decompression rates were
set to 600 and 1200 MPa min1, respectively. The temper-
ature of the compression ﬂuid and sample were monitored
using a type T thermocouple attached to the sample car-
rier. HPP treatment was replicated on diﬀerent days. For
acetic acid-treated samples, prawn muscles were sub-
merged in acetic acid (commercially available white vine-
gar) at pH 2.5 for 15 min. The prawn muscles without
any processing were used as control.
The method described by Faisal et al. (2019c) was
implemented for the extraction of proteins from the
control, HPP and acetic acid-treated samples. In brief,
fresh prawn muscles were homogenised using a labora-
tory blender (Waring 8011ES blender, NJ, USA) in
phosphate-buﬀered saline solution (pH 7.4) at 1:3 ratio
for 5 min. The protein slurry was agitated at 4 °C for
3 h, followed by centrifugation (Beckman Coulter
Avanti J-26S XPI centrifuge, CA, USA) at 4 °C and
speed of 29 400 g for 15 min. The supernatant of the
protein mixture was separated utilising micropipette
and stored in properly labelled sealed containers at
80 °C until further analysis.
Determination of protein content
The total protein content of each sample was deter-
mined by the Kjeldahl method and Bradford Assay kit
(Bio-Rad Laboratories, Sydney, NSW, Australia), fol-
lowing the manufacturer’s instructions. For Kjeldahl
method, a Foss 2020 Digester Unit DS20 and Foss
2012 Distilling Unit (Hillerod, Sweden) were used for
sample digestion and distillation, respectively. Bovine
serum albumin (BSA) was used as the protein standard
for the Bradford method (Kamath et al., 2013).
Protein profiling by reversed-phase high-performance
liquid chromatography (HPLC)
The proteins in control and treated (acetic acid and
HPP) samples were analysed using a reversed-phase
© 2019 The Authors. International Journal of Food Science & Technology published by John Wiley &
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HPLC (SHIMADZU, Prominence-i, LC-2030C,
Tokyo, Japan) and a Jupiter analytical column
(250 9 4.6 mm, particle size 5 lM, pore size 300 A,
connected to a security guard cartridge, wide-pore
C18, 4 9 3.0 mm, Phenomenex, Torrance, CA, USA).
The mobile phase consisted of the following: (i)
HPLC-grade water with 0.1% TFA (triﬂuoroacetic
acid) and (ii) 0.1% TFA in acetonitrile with the fol-
lowing gradient: 5% to 90% B from 0.1 min to
50 min, then 90% B for 5 min after which it reverted
to 5% B for least 5 min (total run time: 60 min) at
room temperature. A 10 lL sample was injected
at each run, and the ﬂow rate was maintained at
0.2 mL min1. Protein elution was monitored at 280
nm with UV detector.
Large scale protein isolation by preparative HPLC
The isolation of protein fractions in a sustainable con-
tent from diﬀerent samples was conducted using a
Varian HPLC system (Varian Analytical Instruments,
Walnut Creek, CA, USA) equipped with a C18 Jupiter
preparative column (250 9 21.2 mm, particle size
5 lM, pore size 300 A, connected to a security guard
prep cartridge, C18-300A, 250 9 21.2 mm, Phenom-
enex). Exactly, 1 mL sample was injected in each run
and the mobile phase consisted of the following: (i)
HPLC-grade water with 0.1% TFA and (ii) 0.1%
TFA in acetonitrile with ﬂow rate 4.28 mL min1. The
following gradient was maintained for the separation
of proteins: 5% to 90% B from 0.1 min to 50 min,
then 90% B for 5 min after which it reverted to 5% B
for least 5 min (total run time: 60 min) at room tem-
perature. Proteins elution was monitored at 280 nm
with a UV detector. To collect separated protein frac-
tions, at least 25 runs/samples were performed. Total
thirteen protein fractions from each sample were col-
lected separately, and same fractions were pooled
together in Falcon tubes. The eluted protein fractions
in the control sample were marked as A1 to A13,
whereas for acid and HPP samples marked as B1 to
B13 and C1 to C13, respectively. Eluted protein frac-
tions were frozen separately followed by freeze-drying
(Dynavac FD 300 Freeze Drier, Melbourne, VIC, Aus-
tralia) to concentrate the protein fractions. The freeze-
dried fractions were resuspended in 2.5 mL RPMI-1640
medium to perform the following analysis.
Detection of allergenic protein fractions from separated
samples using ELISA kit
ELISA is a widely accepted immunological based tech-
nique, used for fast detection and quantiﬁcation of
antigenicity (Faisal et al., 2019b). Detection of aller-
genic protein fractions was performed using a Sand-
wich ELISA kit (RIDASCREENFAST Crustacean,
R-Biopharm, Darmstadt, Hessen, Germany). Samples
were analysed following manufacturer’s instructions as
described by Faisal et al. (2019c). In brief, extracted
protein fractions (250 lg mL1) were each diluted 20-
fold with extraction buﬀer, respectively, followed by
centrifugation at 2500 g (Eppendorf centrifuge 5810 R,
Hamburg, Germany) for 10 min. Exactly, 100 lL/well/
sample was added into antibody pre-coated 96-mi-
crowell plate and incubated at room temperature for
10 min. The 96-microwell plate was washed three
times with washed buﬀer followed by addition of
100 lL conjugate solution to each well and again incu-
bated at room temperature for 10 min. After subse-
quent washing, 100 lL of chromogen was added/well
and incubated in the dark at room temperature for
10 min. Finally, 100 lL of stop solution was added to
each well and absorbance was measured within 10 min
using ELISA plate reader (iMark microplate absor-
bance reader, Bio-Rad, Tokyo, Japan) at 450 nm.
Isolation of human peripheral blood mononuclear cells
(PBMCs)
Peripheral blood mononuclear cells used in the current
study have been obtained by meeting requirements of
the National Health and Medical Research Council
(National Health and Medical Research Council,
2007). Ethics application (ID: HRE16-058) has been
approved by the Victoria University Human Research
Ethics Committee. The Australian Red Cross Blood
Services (Melbourne, Australia) supplied buﬀy coats
from healthy donors. Isolation of PBMCs from buﬀy
coat was performed using an established protocol
(Donkor et al., 2012; Bogahawaththa et al., 2018) with
slight modiﬁcations. In brief, 60 mL of buﬀy coat was
diluted with equal amount of phosphate-buﬀered sal-
ine (pH 7.4) and layered gently on Ficoll-Paque Plus
(GE Healthcare Pty Ltd., Silverwater, NSW, Aus-
tralia). After centrifugation (Sorvall-RT7 centrifuge,
DuPont, Newtown, USA) at 400 g for 25 min at
18 °C with no break, the separated layer of PBMCs
was washed twice with 50 mL of RPMI-1640 immedi-
ately and centrifuged at 400 g/wash (18 °C for 10 min
with break). The cell pellet was resuspended in 10 mL
of RPMI-1640, and the cell concentration was calcu-
lated to be 3.5 9 107 cells mL1.
Stimulation of PBMCs with isolated prawn protein
fractions
Stimulation of PBMCs with the isolated nine prawn
protein fractions, namely A9 to A11, control; B9 to
B11, acetic acid; C9 to C11, HPP, was executed as
described by Bogahawaththa et al. (2018) with some
modiﬁcations. Freshly prepared PBMCs (3.5 9 107
cells mL1) were resuspended in RPMI-1640
© 2019 The Authors. International Journal of Food Science & Technology published by John Wiley &
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supplemented with 10% foetal bovine serum and 1%
antibiotic–antimycotic solution (Sigma Aldrich Pty
Ltd., Castle Hill, NSW, Australia). The cells,
1.66 9 106 mL1, were then co-cultured in each well
with 10 lg mL1 of selected prawn protein fractions
in cell culture ﬂasks and incubated at 37 °C in 5%
CO2 for 144 h. For a positive control, 1 lg mL
1 of
lipopolysaccharide (LPS) from Escherichia coli O111:
B4 (Sigma–Aldrich Pty Ltd.) was co-cultured with
PBMCs, whereas unstimulated PBMCs in RPMI-1640
were used as negative control for quantifying basal
cytokine production. Supernatants were collected at 0-,
4-, 8-, 12-, 24-, 48-, 72-, 96-, 120- and 144-h interval
from the ﬂasks and were stored at 80 °C for cytokine
analysis.
Cytokine assays by IgE ELISA
Concentration of diﬀerent cytokines, including inter-
leukin (IL)-4, IL-10, IL-17A and interferon (IFN)-c,
produced by stimulated PBMCs at diﬀerent time peri-
ods in the presence of selected protein stimulants were
quantiﬁed using enzyme-linked immunosorbent assay
(ELISA) (Thermo Fisher Scientiﬁc Australia Pty Ltd.)
according to the manufacturer’s guideline. In brief,
ninety-six well-uncoated ELISA plates (Coaster 9018
ELISA plate) were coated with captured antibody and
incubated at 4 °C overnight under continuous shaking.
After three consecutive washes with 250 lL wash buﬀer
per well, ELISA plate wells were blocked with 200 lL
ELISTOP diluent and incubated for 1 h. Exactly,
100 lL sample/well was added and incubated at 4 °C
overnight under continuous shaking to achieve maxi-
mum sensitivity. The microwells were washed three
times with wash buﬀer followed by addition of 100 lL/
well of diluted detection antibody. Streptavidin-HRP
(100 lL) for detection of IL-4 and IFN-c or avidin-
HRP for IL-10 and IL-17A was added to each well and
incubated at room temperature for 30 min. Following
this step, 100 lL of TMB solution was added to each
well and incubated for 15 min at room temperature.
100 lL of stop solution (2 N H2SO4) was then added to
each well, and absorbance was measured within 10 min
using ELISA plate reader (xMark microplate spec-
trophotometer, Bio-Rad, Tokyo, Japan) at 450 nm.
Characterisation of allergenic protein fractions
Fractions that showed signiﬁcant allergenic reaction
with PBMCs were analysed by a LC/MS/MS using the
QExactive mass spectrometer (Thermo Scientiﬁc, Bre-
men, Germany) coupled online with a RSLC nano
HPLC (Ultimate 3000, Thermo Scientiﬁc). Samples
were concentrated on a 100 lm, 2 cm nanoviper pep-
map100 trap column with 97.5% buﬀer A (0.1%
TFA) at a ﬂow rate of 15 lL min1. The peptides then
eluted and separated with a Thermo RSLC pep-
map100, 75 lm 9 50 cm, 100 A pore size, reversed-
phase nano-column with a 30 min gradient of 92.5%
buﬀer A (0.1% formic acid) to 42.5% B (80% acetoni-
trile 0.1% formic acid), at a ﬂow rate of
250 nL min1. The eluant is nebulised and ionised
using the Thermo nano electrospray source with a dis-
tal coated fused silica emitter (New Objective,
Woburn, MA, USA) with a capillary voltage of
1900V. Peptides were selected for MSMS analysis in
Full MS/dd-MS2 (TopN) mode with the following
parameter settings: TopN 10, resolution 70000, MSMS
AGC target 5e5, 118 ms Max IT, NCE 27, 1.8 m/z
isolation window, and dynamic exclusion was set to
10 s.
Data from LC/MS/MS analysis were exported to
Mascot generic ﬁle format (*.mgf) using proteowizard
3.0.3631 (open source software, http://proteowiza
rd.sourceforge.net) and searched against the Uniprot
Triticumaestivium databases using the MASCOT
search engine (version 2.4, Matrix Science Inc., Lon-
don, UK) with all taxonomy selected. The following
search parameters were used: missed cleavages, 1; pep-
tide mass tolerance, 10 ppm Da; peptide fragment
tolerance, 0.02 Da; peptide charge, 2+, 3+ and 4+;
ﬁxed modiﬁcations, carbamidomethyl; and variable
modiﬁcation, oxidation (Met). Data from LC/MS/MS
run were processed using Byonic (ProteinMetrics) V
3.1-19 with no speciﬁc cleavage sites speciﬁed and a
precursor and fragment mass tolerance of 20 ppm.
Modiﬁcations speciﬁed were Carbamidomethyl @C
ﬁxed and Oxidation @M Variable common 1. The
protein output was set to 1% FDR. Moreover, data
from LC/MS/MS run were processed using Peaks stu-
dio version 8 (Bioinformatics solutions using default
settings for data reﬁnement and a parent mass toler-
ance of 15 ppm and fragment tolerance at 0.5 Da with
a max of ﬁve peptide candidates per spectrum).
Statistical analysis
Statistical analysis of results was performed using the
general linear model procedure of the Statistical Anal-
ysis System (SAS v.9.2) with the treatment and replica-
tions as the main factors. The eﬀect of selected prawn
protein fraction on immunogenicity of PBMCs at vari-
ous times was considered signiﬁcant at P ≤ 0.05.
Results and discussion
Profiling and isolation of prawn protein by HPLC
The HPLC protein proﬁles for supernatant mixture of
control and treated (acetic acid and HPP) prawn sam-
ples are shown in Fig. 1(a, b and c), and retention
times of eluted protein fractions are also reported in
© 2019 The Authors. International Journal of Food Science & Technology published by John Wiley &
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Table 1. In the control sample, two protein fractions
(A10 and A11) showed signiﬁcantly higher concentra-
tion than similar protein fractions (B10, B11, C10 and
C11) eluted from the treated samples. However, the
protein fractions C9 derived from HPP showed signiﬁ-
cantly higher concentration than A9 and B9. This was
an indication that treatment had an eﬀect on prawn
proteins due to structural changes as a result of treat-
ment of the proteins (Faisal et al., 2019a,c). The com-
bined eﬀect of HPP and heat induced changes in
primary and secondary structures through altering
inter- and intramolecular bonds especially ionic,
hydrogen and hydrophobic interactions (Chatterjee
et al., 2006; Wang et al., 2013). On the other hand,
Xu et al. (2012) reported that structural modiﬁcation
and aggregation of acid-treated proteins take place
due to noncovalent, especially hydrophobic, attrac-
tions and formation of hydrogen bonds.
Antigenicity determination in isolated protein fractions by
enzyme-linked immunosorbent assay (ELISA)
A sandwich ELISA test conﬁrming antigenicity of pro-
tein fractions in control and treated prawn samples
determined positive antigenicity in four out of thirty-
nine eluted fractions, reported in Table 1. Out of the
four antigens, two (A10 and A11) were from the con-
trol sample, whereas one each (B10 and C9) were from
acetic acid- and HPP-treated samples, respectively.
However, A10 showed the highest antigenicity
(32 lg mL1) followed by C9 and B10. These results
indicate that antigenicity was reduced by 81.25% and
Figure 1 HPLC protein proﬁle of untreated (a);
acetic acid treated (b); and HPP at 120 °C (c) prawn
protein extracts.
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18.75% of C9 and B10, respectively, from a 100% of
A10. Jin et al. (2015) stated that HPP in combination
with temperature converted a-helix proteins into b-
sheets and random coils, which likely masked or
destroyed the antigen-binding epitopes. Furthermore,
the partial solubility of proteins due to acid treatment
likely reduced the active epitopes sites of antigens
(Mohan et al., 2007; Xu et al., 2012) similarly
observed in the current studies. Thus, processing likely
masked or destroyed epitopes binding sites on anti-
gens, resulting in less antigen–antibody binding, as
previously reported (Faisal et al., 2019a,c).
Table 1 Antigenicity (IgG binding) analysis of eluted proteins assessed by ELISA kit
Control (Untreated) Acetic acid treated for 15 min HPP at 120 °C for 10 min
Protein fractions with retention
time (min)
Antigenicity
(IgG)
Protein fractions with retention
time (min)
Antigenicity
(IgG)
Protein fractions with retention
time (min)
Antigenicity
(IgG)
A1 (16.00–18.00) – B1 (16.00–18.00) – C1 (16.00–18.40) –
A2 (18.50–19.50) – B2 (19.40–20.00) – C2 (19.30–20.00) –
A3 (19.55–20.30) – B3 (20.05–20.50) – C3 (20.10–20.40) –
A4 (20.40–21.20) – B4 (20.55–21.20) – C4 (20.50–21.20) –
A5 (21.30–22.50) – B5 (21.30–22.50) – C5 (21.30–22.50) –
A6 (24.50–26.00) – B6 (24.55–25.30) – C6 (24.55–25.50) –
A7 (31.40–32.50) – B7 (31.40–32.20) – C7 (31.40–32.30) –
A8 (34.20–38.20) – B8 (34.00–38.20) – C8 (34.00–38.00) –
A9 (38.50–40.00) – B9 (38.50–40.00) – C9 (38.50–40.00) 26 lg mL1
A10 (40.20–41.55) 32 lg mL1 B10 (40.20–41.50) 6 lg mL1 C10 (40.20–42.00) –
A11 (42.10–44.00) 9 lg mL1 B11 (42.10–43.50) – C11 (42.40–43.50) –
A12 (45.50–47.40) – B12 (45.50–47.40) – C12 (45.50–47.40) –
A13 (53.20–55.10) – B13 (53.20–54.50) – C13 (53.20–54.50) –
(a) (b)
(c) (d)
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Figure 2 Changes in concentrations of cytokines in treated and untreated fractions with time – anti-inﬂammatory IL-10 (a) and IL-4 (b); pro-
inﬂammatory cytokines – IFN-c (c) and IL-17A (d). A10 and A11 from control; B10 from acetic acid treated; C9 from HPP at 120 °C treated;
PC means positive control and NC means negative control.
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In vitro Immunogenicity analysis of selected isolated
protein fractions
Antigenicity analysis of isolated protein fractions
showed that potential allergenic proteins were eluted
between 38.50 and 44.00 min for both control and trea-
ted samples. Based on these ﬁndings, three protein frac-
tions from each treatment were used to challenge
human PBMCs and supernatants collected at diﬀerent
time intervals were analysed for cytokine production
(Fig. 2). Again, four protein fractions (A10, A11, B10
and C9) showed signiﬁcantly (P < 0.05) higher mean
cytokine production in comparison with negative
control. On the other hand, other protein fractions
tested (A9 from control; B9 and B11 from acetic acid;
C10 and C11 from HPP) showed no signiﬁcant
(P > 0.05) diﬀerence in cytokine concentration to nega-
tive control (data not shown). Two types of cytokines,
anti-inﬂammatory (Fig. 2a and b) and pro-inﬂammatory
(Fig. 2c and d), were produced in varying concentrations.
The anti-inﬂammatory cytokine (IL-4 and IL-10) produc-
tion increased in concentration with increasing time up to
48 h, whereas the pro-inﬂammatory cytokines (IFN-c
and IL-17A) did not signiﬁcantly increase in concentra-
tion until after 48 h up to 144 h when IL-4 and IL-10
consistently declined (Fig. 2). Prawn protein is classiﬁed
Table 2 List of identified proteins in protein fractions by LC/MS/MS
Fractions Protein code Identified proteins by LC/MS/MS
Concentration of
protein in
fractions (%)
% of
Coverage
A10 (Control) C3VUU0 Arginine kinase OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=1 40.65 69.38
D3XNS0 Tropomyosin OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=4 37.00 93.66
G3GDS2 Enolase (Fragment) OS=Fenneropenaeus merguiensis OX=71412 GN=eno PE=4
SV=1
11.88 66.67
Q5QD40 Translationally controlled tumour protein OS=Fenneropenaeus merguiensis
OX=71412 PE=2 SV=1
5.00 58.33
S5ZHH2 Haemocyanin OS=Fenneropenaeus merguiensis OX=71412 GN=HC PE=2 SV=1 3.33 19.52
Q07DN6 Farnesoic acid O-methyltransferase short isoform (Fragment)
OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=1
1.62 28.82
D2SSM3 Vitellogenin OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=1 0.52 10.71
A11 (Control) S5ZHH2 Haemocyanin OS=Fenneropenaeus merguiensis OX=71412 GN=HC PE=2 SV=1 35.00 88.05
C3VUU0 Arginine kinase OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=1 34.58 77.25
D3XNS0 Tropomyosin OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=4 20.31 81.69
G3GDS2 Enolase (Fragment) OS=Fenneropenaeus merguiensis OX=71412 GN=eno PE=4
SV=1
8.06 70.08
Q07DN6 Farnesoic acid O-methyltransferase short isoform (Fragment)
OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=1
1.18 30.13
Q5QD40 Translationally controlled tumour protein OS=Fenneropenaeus merguiensis
OX=71412 PE=2 SV=1
0.70 32.74
D2SSM3 Vitellogenin OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=1 0.16 19.56
B10 (Acetic acid
treated)
D3XNS0 Tropomyosin OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=4 27.90 67.25
S5ZHH2 Haemocyanin OS=Fenneropenaeus merguiensis OX=71412 GN=HC PE=2 SV=1 26.25 52.50
C3VUU0 Arginine kinase OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=1 18.51 53.37
G3GDS2 Enolase (Fragment) OS=Fenneropenaeus merguiensis OX=71412 GN=eno PE=4
SV=1
15.68 64.10
Q5QD40 Translationally controlled tumour protein OS=Fenneropenaeus merguiensis
OX=71412 PE=2 SV=1
7.80 76.19
D9I8L2 14-3-3 zeta OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=1 2.11 8.94
A0A0A7D6G0 Beta-1,3-glucan-binding protein OS=Fenneropenaeus merguiensis OX=71412
PE=2 SV=1
1.25 5.98
D2SSM3 Vitellogenin OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=1 0.50 3.13
C9 (HPP) D3XNS0 Tropomyosin OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=4 57.92 94.72
C3VUU0 Arginine kinase OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=1 18.96 67.70
S5ZHH2 Haemocyanin OS=Fenneropenaeus merguiensis OX=71412 GN=HC PE=2 SV=1 15.07 54.01
G3GDS2 Enolase (Fragment) OS=Fenneropenaeus merguiensis OX=71412 GN=eno PE=4
SV=1
3.90 71.79
Q5QD40 Translationally controlled tumour protein OS=Fenneropenaeus merguiensis
OX=71412 PE=2 SV=1
2.16 30.95
D2SSM3 Vitellogenin OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=1 1.15 29.96
D9I8L2 14-3-3 zeta OS=Fenneropenaeus merguiensis OX=71412 PE=2 SV=1 0.84 39.43
© 2019 The Authors. International Journal of Food Science & Technology published by John Wiley &
Sons Ltd on behalf of Institute of Food, Science and Technology (IFSTTF).
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as a type 1 IgE-mediated allergy; hence, protein fractions
A10, A11, B10 and C9 stimulated PBMCs to release
Th2-type cytokines IL-4 and IL-10 (Untersmayr & Jen-
sen-Jarolim, 2006; Barnes, 2011). However, the presence
of antigens continued to stimulate the production of pro-
inﬂammatory cytokines, which likely maintained home-
ostasis in the culture medium (Wang et al., 2012; Galvez,
2014). In general, fraction A10 showed signiﬁcantly
Figure 3 Characterisation of protein fractions by LC/MS/MS.
© 2019 The Authors. International Journal of Food Science & Technology published by John Wiley &
Sons Ltd on behalf of Institute of Food, Science and Technology (IFSTTF).
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higher cytokine production compared with fractions C9
and B10, indicative of eﬀect of treatment on prawn pro-
teins resulting in reduced immunogenicity. In another
study, Abramovitch et al. (2017) also reported lower
cytokine production for treated prawn muscle extract.
Characterisation of prawn protein fractions by LC/MS/MS
The allergenic protein fractions characterised by LC/
MS/MS are listed in Table 2, and the amino acid
sequences of nine identiﬁed proteins are represented in
Fig. 3. In the control sample (A10, A11), the following
proteins were identiﬁed: tropomyosin (37 KDa), argi-
nine kinase (40 KDa), haemocyanin (75 KDa), enolase
(12 KDa), translationally controlled tumour protein
(19 KDa), vitellogenin (283 KDa) and farnesoic acid
O-methyltransferase short isoform (26 KDa), as well
as lesser proteins with lower molecular masses. On the
other hand, with the exception of farnesoic acid O-
methyltransferase short isoform (26 KDa) protein and
some lesser molecular mass proteins in A10, B10 and
C9 contained similar proteins in addition 14-3-3 zeta
(27 KDa) identiﬁed. Khanaruksombat et al. (2014)
identiﬁed vitellogenin and 14-3-3 zeta as minor aller-
gens in Banana prawn ovaries and therefore are likely
to be allergenic in muscle. In addition, translationally
controlled tumour protein was identiﬁed in all frac-
tions, and however, its impact on immunogenicity
needs further investigation. Furthermore, in acetic
acid-treated fraction B10, beta-1,3-glucan-binding
(227 KDa) protein was identiﬁed (not in control and
C9). Structural changes due to acid treatment (Mohan
et al., 2007; Faisal et al., 2019a,c) and the presence of
identiﬁed protein likely resulted in the lowest anti-
genicity and immunogenicity observed. As a conse-
quence of treatment, LC/MS/MS identiﬁcation showed
the per cent of coverage (% of protein match with
Database) signiﬁcantly changed, compared with con-
trol. Thus, the disappearance of proteins from A10
and appearance of new proteins in B10 and C9 frac-
tions are indications of processing eﬀect on changes in
prawn proteins; however, their impact on immuno-
genicity need further investigation. Tropomyosin is a
major allergenic protein of Banana prawn (Faisal
et al., 2019a,c), whereas arginine kinase has been
reported as a minor allergen in diﬀerent species of
prawns (Kamath et al., 2013, 2014; Rahman et al.,
2013), and haemocyanin and enolase fragment have
also been reported as minor allergens in Banana prawn
muscle (Khanaruksombat et al., 2014).
Conclusion
Processing of prawn muscle with HPP and acetic acid
separately showed signiﬁcant lower pro- and anti-in-
ﬂammatory cytokine production resulting in decreased
immunogenicity compared to control. Characterization
of treated and untreated fractions showed four com-
mon proteins (tropomyosin, arginine kinase, hemo-
cyanin and enolase) having allergenic properties in
prawn muscle. Whereas, other two proteins (vitel-
logenin and 14-3-3 zeta) identiﬁed are likely to have
minor allergenic properties in prawn overies. The
remaining three proteins (beta-1,3-glucan-binding pro-
tein, translationally controlled tumour protein and far-
nesoic acid O-methyltransferase short isoform protein)
isolated from treated and untreated fractions need fur-
ther studies into their immunogenic properties.
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